This inventor holds 1 USPTO granted patent. Top assignee: Baylor Research Institute. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Alexander Link
Introduction
Alexander Link is a notable inventor based in Dallas, TX (US). He has made significant strides in the field of gastroenterological cancer diagnostics. His work focuses on the identification of microRNAs (miRNAs) in fecal samples, which has the potential to revolutionize cancer detection methods.
Latest Patents
Alexander Link holds a patent for the invention titled "Identification of microRNAs (miRNAs) in fecal samples as biomarkers for gastroenterological cancers." This innovative method is described as simple, rapid, inexpensive, and promising for commercial use. It detects miRNA-based biomarkers directly from human stool specimens without the need for prior extraction. The differential expression of specific microRNAs in the stool of colorectal cancer (CRC) and adenoma patients suggests that fecal microRNAs could serve as novel biomarkers for colorectal neoplasia detection. This method has diagnostic, prognostic, and therapeutic relevance for gastroenterological cancers and other gastrointestinal diseases.
Career Highlights
Alexander Link is affiliated with the Baylor Research Institute, where he continues to contribute to advancements in medical diagnostics. His work is pivotal in enhancing the understanding and detection of gastroenterological cancers.
Collaborations
He has collaborated with esteemed colleagues such as Ajay Goel and C. Richard Boland, further enriching his research and innovation efforts.
Conclusion
Alexander Link's contributions to the field of cancer diagnostics through his innovative patent highlight the importance of research in improving healthcare outcomes. His work exemplifies the potential of using microRNA biomarkers for early detection of diseases, paving the way for future advancements in medical technology.